Collaboration Announced to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors

Collaboration brings together Avectas’ breakthrough cell engineering technology and Inceptor Bio’s CAR-T platform

MORRISVILLE, NC and DUBLIN, Ireland — October 12, 2022: Inceptor Bio, a cell therapy biotechnology company and Avectas, a cell engineering technology leader, announce their collaboration to improve the development and manufacturing of next-generation CAR-T cell therapies for the treatment of solid tumors.

Read more….